FFreeCE GuideContinuing education · No cost

Pharmacy Times Continuing Education

Optimizing HER2-Targeted Therapies in Non-Small Cell Lung Cancer: A Pharmacist’s Guide to Biomarker Testing, Therapeutic Selection, and Toxicity Management

Optimizing HER2-Targeted Therapies in Non-Small Cell Lung Cancer: A Pharmacist’s Guide to Biomarker Testing, Therapeutic Selection, and Toxicity Management. A continuing education activity offered by Pharmacy Times Continuing Education.

Available on demand1.5 ACPE CPEFree course and certificate

Before you enroll

Is this the right course for you?

Optimizing HER2-Targeted Therapies in Non-Small Cell Lung Cancer: A Pharmacist’s Guide to Biomarker Testing, Therapeutic Selection, and Toxicity Management is offered by Pharmacy Times Continuing Education for pharmacists. Topics in this listing: Pharmacology.

Check the credit type and approval notes below against your credential. The provider handles enrollment, completion and the certificate.

Course details

Provider
Pharmacy Times Continuing Education
Format
On demand
Profession
Pharmacists
Credit expiration
Apr 29, 2027
Registration
Free provider account required
Last checked
Oct 9, 2026
Language
English

Credits & eligibility

1.5 ACPE CPE

Provider-stated credit; confirm acceptance for your license and jurisdiction.

Listed roles: Pharmacist

Approval / program ID: 0290-0000-26-101-H05-P

State scope: No individual state acceptance claim is made in this listing.

ACPE

What’s free

Course access
$0
Assessment
$0
Certificate
$0
Credit reporting
$0 — no separate reporting fee identified

The provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.

How to earn your credit

  1. Create a free PTCE account and complete the activity in its entirety.
  2. Complete the pretest, posttest and evaluation as required, then request CPE Monitor credit before the activity expires.

Questions about this course

Is “Optimizing HER2-Targeted Therapies in Non-Small Cell Lung Cancer: A Pharmacist’s Guide to Biomarker Testing, Therapeutic Selection, and Toxicity Management” completely free?

The recorded cost is $0 for learning, assessment and the certificate, with no separate reporting fee identified. Pharmacy Times Continuing Education requires a free account. The provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.

Which credit can I earn?

The provider lists 1.5 ACPE CPE. Recorded roles: Pharmacist. Match the individual track below to your credential and board before enrolling.

When can I take this course?

This is an on-demand activity in the current collection; follow the source link to begin. The recorded credit expiration date is 2027-04-29.

What do I need to do for the certificate?

Create a free PTCE account and complete the activity in its entirety. Complete the pretest, posttest and evaluation as required, then request CPE Monitor credit before the activity expires. Completion and certificate delivery are handled by Pharmacy Times Continuing Education; saving this listing does not enroll you or claim credit.

Sources & verification

These are the primary pages supporting this listing. Course recognition and board acceptance should be confirmed for your credential before enrollment.

Your next credential

Free exam preparation for pharmacists

Preparing for an exam, too? Explore free practice questions and explanations on OpenExamPrep.

OpenExamPrepFree exam preparation
Free practice

NABP NAPLEX North American Pharmacist Licensure Examination

200 practice questions Free practice

NABP MPJE Multistate Pharmacy Jurisprudence Examination

199 practice questions
Explore all 54 exams for pharmacists →

These are exam-preparation resources, separate from continuing education credit. Exam registration fees and eligibility are set by the exam sponsor.

Keep exploring

More for your profession
Pharmacy Times Continuing EducationFree
Available on demand

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management. A continuing education activity offered by Pharmacy Times Continuing Education.

1 ACPE CPEOn demand
Checked Oct 9, 2026